DEF14A

Company

AGIOS PHARMACEUTICALS, INC.

Filed

April 29, 2015

Period of Report

June 23, 2015

Accession Number

0001193125-15-156630

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →